Rutgers scientist creates “virtual biopsy” device to detect skin tumors

Huge Two-Day Clean Sweep Auction July 24-25th. Click Here to Bid!

advertisement
Current Location:
>
>
> This Story

Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

CT Homepage

Fujifilm presents imaging portfolio for better patient experiences and outcomes at AHRA 2019

AHRA and Canon Medical Systems support medical imaging innovation with the 12th annual putting patients first program

Johns Hopkins develops criteria for diagnostic imaging

Prestige Medical Imaging partners with Xoran Technologies

RAPID receives registration approval in Japan

NLST follow up reaffirms that low dose CT reduces lung cancer mortality

VIVO system cleared by FDA

Russian scientists patent new agent for X-ray

UT Dallas acquires new microCT-enhanced deep-tissue optical imaging system

RAPID by iSchemaView now available for use in Mexico

Rutgers scientist creates “virtual biopsy” device to detect skin tumors

Press releases may be edited for formatting or style
Using sound vibrations and pulses of near-infrared light, a Rutgers University scientist has developed a new “virtual biopsy” device that can quickly determine a skin lesion’s depth and potential malignancy without using a scalpel.

The ability to analyze a skin tumor non-invasively could make biopsies much less risky and distressing to patients, according to a report in Wiley Online Library. Currently, physicians who perform surgical biopsies often don’t know the extent of a lesion – and whether it will be necessary to refer the patient to a specialist for extensive tissue removal or plastic surgery – until surgery has already begun.

Story Continues Below Advertisement

THE (LEADER) IN MEDICAL IMAGING TECHNOLOGY SINCE 1982. SALES-SERVICE-REPAIR

Special-Pricing Available on Medical Displays, Patient Monitors, Recorders, Printers, Media, Ultrasound Machines, and Cameras.This includes Top Brands such as SONY, BARCO, NDS, NEC, LG, EDAN, EIZO, ELO, FSN, PANASONIC, MITSUBISHI, OLYMPUS, & WIDE.



The first-of-its-kind experimental procedure, called vibrational optical coherence tomography (VOCT), creates a 3-D map of the legion’s width and depth under the skin with a tiny laser diode. It also uses soundwaves to test the lesion’s density and stiffness since cancer cells are stiffer than healthy cells. An inch-long speaker applies audible soundwaves against the skin to measure the skin’s vibrations and determine whether the lesion is malignant.

“This procedure can be completed in 15 minutes with no discomfort to the patient, who feels no sensation from the light or the nearly inaudible sound. It’s a significant improvement over surgical biopsies, which are invasive, expensive and time consuming,” said lead researcher Frederick Silver, a professor of pathology and laboratory medicine at Rutgers Robert Wood Johnson Medical School.

The study found that a prototype VOCT device, which awaits FDA approval for large-scale testing, is able to accurately distinguish between healthy skin and different types of skin lesions and carcinomas. The researchers tested the device over six months on four skin excisions and on eight volunteers without skin lesions. Further studies are needed to fine-tune the device’s ability to identify a lesion’s borders and areas of greatest density and stiffness, which would allow physicians to remove tumors with minimally invasive surgery.

Ruchit Shah, who was a Rutgers doctoral candidate at biomedical engineering at the time of the study, and researchers at the Neigel Center for Cosmetic and Laser Surgery and Center for Advanced Eye Care, co-authored the study.

CT Homepage


You Must Be Logged In To Post A Comment